Fenaux, P., Mufti, G., Hellström-Lindberg, E., Santini, V., Gattermann, N., Sanz, G., . . . Silverman, L. (2008). Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: An update. Cancer Intelligence.
Citação norma ChicagoFenaux, P., et al. Azacitidine Prolongs Overall Survival and Reduces Infections and Hospitalizations in Patients With WHO-defined Acute Myeloid Leukaemia Compared With Conventional Care Regimens: An Update. Cancer Intelligence, 2008.
MLA CitationFenaux, P., et al. Azacitidine Prolongs Overall Survival and Reduces Infections and Hospitalizations in Patients With WHO-defined Acute Myeloid Leukaemia Compared With Conventional Care Regimens: An Update. Cancer Intelligence, 2008.